These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The current and future use of thrombolytic therapy. Sherry S; Gustafson E Annu Rev Pharmacol Toxicol; 1985; 25():413-31. PubMed ID: 3890708 [No Abstract] [Full Text] [Related]
12. [When is fibrinolytic therapy indicated?]. Woitinas F Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218 [No Abstract] [Full Text] [Related]
13. The hematologic consequences of thrombolytic therapy. Fletcher AP; Alkjaersig NK Prog Hematol; 1986; 14():183-200. PubMed ID: 2935903 [No Abstract] [Full Text] [Related]
14. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
18. Thrombolytic therapy. Collen D; Lijnen HR Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640 [No Abstract] [Full Text] [Related]
19. Current concepts: guidelines for the use of thrombolytic agents. Bell WR; Meek AG N Engl J Med; 1979 Dec; 301(23):1266-70. PubMed ID: 503130 [No Abstract] [Full Text] [Related]
20. [Streptokinase or urokinase: the elements of choice]. Pâques EP Haemostasis; 1986; 16 Suppl 4():21-5. PubMed ID: 2429902 [No Abstract] [Full Text] [Related] [Next] [New Search]